Glucose-6-phosphate isomerase deficiency.

Area of Science:

• Biochemistry
• Genetics
• Hematology

Background:

• Erythrocytes rely on glycolysis, oxidative pentose phosphate pathway, and glutathione cycle for metabolic needs.
• Hereditary enzyme deficiencies in these pathways are known, with glucose-6-phosphate isomerase (GPI) deficiency being a common erythroenzymopathy.
• GPI deficiency is linked to non-spherocytic hemolytic anemia of varying severity and potential neurological impairment.

Purpose of the Study:

• To review the clinical presentation of GPI deficiency.
• To explore the biochemical and molecular studies related to GPI deficiency.
• To examine structure-function relationships, the molecular basis of neurological issues, and anemia severity correlations.

Main Methods:

• Review of clinical patterns of GPI deficiency.
• Analysis of biochemical and molecular studies.
• Examination of structure-function relationships and mutation data.

Main Results:

• GPI deficiency is the second most frequent glycolytic erythroenzymopathy.
• Mutant GPI products often show instability and altered catalytic activity.
• Twenty-nine mutations have been reported at the nucleotide level.

Conclusions:

• GPI deficiency presents with variable hemolytic anemia and potential neurological symptoms.
• Understanding the molecular defects is crucial for correlating genotype with phenotype.
• Further research into structure-function relationships can elucidate disease mechanisms.